Table 1.
Baseline characteristics of the NTG and HTG groups.
| Parameters | NTG group (n = 1302) | HTG group (n = 672) |
|---|---|---|
| Age, y | 40.89 ± 11.99 | 42.37 ± 10.38∗ |
| Gender, males/females | 632/670 | 374/298 |
| WC, cm | 89.12 ± 5.42 | 93.68 ± 6.62∗∗ |
| BMI, kg/m2 | 23.32 ± 4.40 | 26.14 ± 3.85∗∗ |
| TC, mmol/L | 4.77 ± 0.85 | 5.25 ± 0.90∗∗ |
| LDL-C, mmol/L | 2.79 ± 0.72 | 2.96 ± 0.74∗∗ |
| HDL-C, mmol/L | 1.34 ± 0.30 | 1.06 ± 0.21∗∗ |
| TG, mmol/L | 0.95 (0.71–1.26) | 2.24 (1.95–2.88)∗∗ |
| FBG, mmol/L | 5.33 ± 0.38 | 5.47 ± 0.34∗∗ |
| FINS, mIU/L | 9.80 (6.77–13.79) | 16.17 (11.25–21.93)∗∗ |
| HOMA-IR | 2.30 (1.56–3.29) | 3.86 (2.76–5.42)∗∗ |
| HOMA-β | 110.30 (77.02–154.92) | 164.15 (114.05–228.80)∗∗ |
Data are means ± SD unless indicated otherwise. TG, FINS, HOMA-IR, and HOMA-β are shown as medians and upper and lower quartiles. WC: waist circumference; BMI: body mass index; TC: total cholesterol; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; TG: triglyceride; FBG: fasting blood glucose; FINS: fasting insulin; HOMA-IR: homeostasis model assessment of insulin resistance; HOMA-β: homeostasis model assessment of β-cell function. ∗Significantly different at P < 0.05 versus control; ∗∗significantly different at P < 0.01 versus control.